An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 208112
Company: ACTAVIS LLC

Products on ANDA 208112

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
METHYLNALTREXONE BROMIDE	METHYLNALTREXONE BROMIDE	8MG/0.4ML (8MG/0.4ML)	SOLUTION;SUBCUTANEOUS	Discontinued	None	No	No
METHYLNALTREXONE BROMIDE	METHYLNALTREXONE BROMIDE	12MG/0.6ML (12MG/0.6ML)	SOLUTION;SUBCUTANEOUS	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 208112

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/26/2024	ORIG-1	Approval		STANDARD		Label is not available on this site.

Top